Effects of a CRF2R agonist and exercise on mdx and wildtype skeletal muscle
β Scribed by Julie E. Hall; Jan J. Kaczor; Bart P. Hettinga; Robert J. Isfort; Mark A. Tarnopolsky
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 133 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The hypothesis we tested was that administering corticotropinβreleasing factor receptor agonists preserves muscle mass during cancer that is related to changes in tissue gene expression. cDNA microarrays were used to compare mRNAs from muscle and adipose tissues of nonβtreated and agoni
Duchenne muscular dystrophy is an X-linked devastating disease due to the lack of expression of a functional dystrophin. Unfortunately, the dystrophin-deficient mdx mouse model does not present clinical signs of dystrophy before the age of 18 months, and the role of dystrophin in fiber integrity is